Raising $200M & Building AI for Drug Discovery | BenchSci Co-founder and CEO, Liran Belenzon

Most people don’t realize how broken drug discovery really is. According to Liran Belenzon, companies can spend seven years and hundreds of millions of dollars on a drug candidate—only to see it fail in human trials. In this ...

In this special co-hosted episode of The Jess Larsen Show on Innovation & Leadership, Jess Larsen is joined by top Compass broker Holly Parker for a fascinating conversation with Cayman Islands attorney Daniel Altneu of Bedel...

What does it really take to build a $100M–$300M+ home—and work with some of the wealthiest people in the world? In this episode, Grant Bowen, founder of Peak Projects, breaks down the hidden world behind ultra-luxury residential development. From managing complex projects to acting as a trusted adv…

Former Navy SEAL Diego Ugalde returns to The Jess Larsen Show for one of our most thought-provoking conversations yet. In this throwback episode, Diego opens up about the journey behind his book Leading From the Deep and the ...

In this episode of Innovation & Leadership, Jess Larsen sits down with Alex Yeh, founder of GMI Cloud, to explore the rise of AI infrastructure and the idea of a new “AI internet.” Alex explains how this next wave of computin...

In this episode of The Jess Larsen Show on Innovation & Leadership , Jess sits down with serial entrepreneur Diaz Nesamoney to explore the evolution of data, AI, and the future of commerce. Diaz shares his journey from growin...